Atlas Trials

Race Impact on Efficacy of Niraparib Plus Abiraterone Acetate and Prednisone in Patients With Homologous Repair Deficient Castration-resistant Prostate Cancer

Clinical trial NCT06527690 · WITHDRAWN

Trial details

NCT number
NCT06527690
Sponsor
Latin American Cooperative Oncology Group
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate CancerCastrate Resistant Prostate CancerHomologous Recombination Deficiency
Start date
2025-04-30
Primary completion
2027-09-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.